Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug.
Business
·
Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion
CN
CitrixNews Staff
Originally reported by New York Times. Read the full story at the original source.
Related Articles
Business
Adidas Hopes Its World Cup Moment Can Drive U.S. Sales
Nearly everything on the field on Sunday will bear the German company’s logo. Bjørn Gulden, the chief executive, says he...
CitrixNews Staff
·
31 minutes ago
Business
Fifa to announce record $15bn World Cup revenue, smashing expectations
Hospitality and secondary ticket market help fuel riseGianni Infantino will feel this shores up his positionFifa will an...
CitrixNews Staff
·
45 minutes ago
Business
We love you, Don Gonyea: Veteran NPR correspondent hangs up his mic after 4 decades
Media We love you, Don Gonyea: Veteran NPR correspondent hangs up his mic after 4 decades July 18, 20265:20 PM ET By&...
CitrixNews Staff
·
1 hour ago
Business
Madison Square Garden Sues Wired Magazine Over L.G.B.T.Q. Tracking Report
The Manhattan venue claims a July article from the technology magazine falsely implied that it tracked information about...
CitrixNews Staff
·
2 hours ago